Multiplicative interactions to enhance gabapentin to treat neuropathic pain

European Journal of Pharmacology

Volumn 598, Issue 1-3, 2008, Pages 21-26

  Hayashida, Ken ichiro ^a   Eisenach, James C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Descending inhibition; Donepezil; Duloxetine; Gabapentin; Neuropathic pain

Indexed keywords

ATROPINE; DONEPEZIL; DULOXETINE; GABAPENTIN; IDAZOXAN;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; MALE; MOTOR COORDINATION; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; RAT; ROTAROD TEST; SEDATION; SPINAL NERVE;

AMINES; ANALGESICS; ANIMALS; CYCLOHEXANECARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GAMMA-AMINOBUTYRIC ACID; INDANS; INJECTIONS, SPINAL; LIGATION; MALE; NEUROTRANSMITTER UPTAKE INHIBITORS; NOOTROPIC AGENTS; PAIN; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; PHYSICAL STIMULATION; PIPERIDINES; POSTURAL BALANCE; PSYCHOMOTOR PERFORMANCE; RATS; RATS, SPRAGUE-DAWLEY; SPINAL NERVES; THIOPHENES;

EID: 54049119144     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.09.004     Document Type: Article

References (34)

1. Bomholt S.F., Mikkelsen J.D., and Blackburn-Munro G. Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain. Neuropharmacology 48 (2005) 252-263
2. Bymaster F.P., Dreshfield-Ahmad L.J., Threlkeld P.G., Shaw J.L., Thompson L., Nelson D.L., Hemrick-Luecke S.K., and Wong D.T. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology 25 (2001) 871-880
3. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., and Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods 53 (1994) 55-63
4. Chen S.R., and Pan H.L. Effect of systemic and intrathecal gabapentin on allodynia in a new rat model of postherpetic neuralgia. Brain Res. 1042 (2005) 108-113
5. Clayton B.A., Hayashida K., Childers S.R., Xiao R., and Eisenach J.C. Oral donepezil reduces hypersensitivity after nerve injury by a spinal muscarinic receptor mechanism. Anesthesiology 106 (2007) 1019-1025
6. Eisenach J.C. Muscarinic-mediated analgesia. Life Sci. 64 (1999) 549-554
7. Goldstein D.J., Lu Y., Detke M.J., Lee T.C., and Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 116 (2005) 109-118
8. Hayashida K.I., Bynum T., Vincler M., and Eisenach J.C. Inhibitory M2 muscarinic receptors are upregulated in both axotomized and intact small diameter dorsal root ganglion cells after peripheral nerve injury. Neuroscience 140 (2006) 259-268
9. Hayashida K., DeGoes S., Curry R., and Eisenach J.C. Gabapentin activates spinal noradrenergic activity in rats and humans and reduces hypersensitivity after surgery. Anesthesiology 106 (2007) 557-562
10. Hayashida K., Parker R., and Eisenach J.C. Oral gabapentin activates spinal cholinergic circuits to reduce hypersensitivity after peripheral nerve injury and interacts synergistically with oral donepezil. Anesthesiology 106 (2007) 1213-1219
11. Hayashida K.I., Clayton B.A., Johnson J.E., and Eisenach J.C. Brain derived nerve growth factor induces spinal noradrenergic fiber sprouting and enhances clonidine analgesia following nerve injury in rats. Pain 136 (2008) 348-355
12. Iyengar S., Webster A.A., Hemrick-Luecke S.K., Xu J.Y., and Simmons R.M. Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats. J. Pharmacol. Exp. Ther. 311 (2004) 576-584
13. Jones S.L. Descending noradrenergic influences on pain. Prog. Brain Res. 88 (1991) 381-394
14. Kim S.H., and Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50 (1992) 355-363
15. Laird M.A., and Gidal B.E. Use of gabapentin in the treatment of neuropathic pain. Ann. Pharmacother. 34 (2000) 802-807
16. Li C.Y., Zhang X.L., Matthews E.A., Li K.W., Kurwa A., Boroujerdi A., Gross J., Gold M.S., Dickenson A.H., Feng G., and Luo Z.D. Calcium channel alpha(2)delta(1) subunit mediates spinal hyperexcitability in pain modulation. Pain 125 (2006) 20-34
17. McCleane G.J., Suzuki R., and Dickenson A.H. Does a single intravenous injection of the 5HT3 receptor antagonist ondansetron have an analgesic effect in neuropathic pain? A double-blinded, placebo-controlled cross-over study. Anesth. Analg. 97 (2003) 1474-1478
18. Millan M.J. Descending control of pain. Prog. Neurobiol. 66 (2002) 355-474
19. Obata H., Saito S., Koizuka S., Nishikawa K., and Goto F. The monoamine-mediated antiallodynic effects of intrathecally administered milnacipran, a serotonin noradrenaline reuptake inhibitor, in a rat model of neuropathic pain. Anesth. Analg. 100 (2005) 1406-1410 table of contents
20. Pan H.L., Eisenach J.C., and Chen S.R. Gabapentin suppresses ectopic nerve discharges and reverses allodynia in neuropathic rats. J. Pharmacol. Exp. Ther. 288 (1999) 1026-1030
21. Porreca F., Ossipov M.H., and Gebhart G.F. Chronic pain and medullary descending facilitation. Trends Neurosci. 25 (2002) 319-325
22. Rahman W., Suzuki R., Webber M., Hunt S.P., and Dickenson A.H. Depletion of endogenous spinal 5-HT attenuates the behavioural hypersensitivity to mechanical and cooling stimuli induced by spinal nerve ligation. Pain 123 (2006) 264-274
23. Randall L.O., and Selitto J.J. A method for measurement of analgesic activity on inflamed tissue. Arch. Int. Pharmacodyn. Ther. 111 (1957) 409-419
24. Sindrup S.H., Otto M., Finnerup N.B., and Jensen T.S. Antidepressants in the treatment of neuropathic pain. Basic Clin. Pharmacol. Toxicol. 96 (2005) 399-409
25. Slatkin N.E., and Rhiner M. Treatment of opiate-related sedation: utility of the cholinesterase inhibitors. J. Support Oncol. 1 (2003) 53-63
26. Suzuki R., Rahman W., Hunt S.P., and Dickenson A.H. Descending facilitatory control of mechanically evoked responses is enhanced in deep dorsal horn neurones following peripheral nerve injury. Brain Res. 1019 (2004) 68-76
27. Suzuki R., Rygh L.J., and Dickenson A.H. Bad news from the brain: descending 5-HT pathways that control spinal pain processing. Trends Pharmacol. Sci. 25 (2004) 613-617
28. Takasu K., Honda M., Ono H., and Tanabe M. Spinal alpha(2)-adrenergic and muscarinic receptors and the NO release cascade mediate supraspinally produced effectiveness of gabapentin at decreasing mechanical hypersensitivity in mice after partial nerve injury. Br. J. Pharmacol. 148 (2006) 233-244
29. Takasu K., Ono H., and Tanabe M. Gabapentin produces PKA-dependent pre-synaptic inhibition of GABAergic synaptic transmission in LC neurons following partial nerve injury in mice. J. Neurochem. 105 (2008) 933-942
30. Takeuchi Y., Takasu K., Honda M., Ono H., and Tanabe M. Neurochemical evidence that supraspinally administered gabapentin activates the descending noradrenergic system after peripheral nerve injury. Eur. J. Pharmacol. 556 (2007) 69-74
31. Tallarida R.J., Porreca F., and Cowan A. Statistical analysis of drug-drug and site-site interactions with isobolograms. Life Sci. 45 (1989) 947-961
32. Tanabe M., Takasu K., Kasuya N., Shimizu S., Honda M., and Ono H. Role of descending noradrenergic system and spinal alpha2-adrenergic receptors in the effects of gabapentin on thermal and mechanical nociception after partial nerve injury in the mouse. Br. J. Pharmacol. 144 (2005) 703-714
33. Xu Z., Tong C., Pan H.L., Cerda S.E., and Eisenach J.C. Intravenous morphine increases release of nitric oxide from spinal cord by an alpha-adrenergic and cholinergic mechanism. J. Neurophysiol. 78 (1997) 2072-2078
34. Yaksh T.L., and Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol. Behav. 17 (1976) 1031-1036